בית החולים אי.מ.מ.ס הסקוטי, הידוע בעיקר כ"בית החולים האנגלי", הוא בית חולים כללי בנצרת.

During the past decade, Nazareth EMMS Hospital conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 11 clinical trials were completed, i.e. on average, 68.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nazareth EMMS Hospital" #1 sponsor was "The Nazareth Hospital, Israel" with 4 trials, followed by "MGC Pharmaceuticals d.o.o" with 3 trials sponsored, "Shire" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nazareth EMMS Hospital" #1 collaborator was "Nazareth Hospital" with 2 trials as a collaborator, "Barzilai Medical Center" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "HaEmek Medical Center, Israel" with 1 trials as a collaborator and "Hadassah Medical Organization" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Nazareth EMMS Hospital" are "Corona Virus Infection" (3 trials), "Ulcerative Colitis" (3 trials), "Cardiovascular Disease" (2 trials), "Chronic Kidney Disease" (2 trials) and "Covid19" (2 trials). Many other conditions were trialed in "Nazareth EMMS Hospital" in a lesser frequency.

Most popular intervention types in "Nazareth EMMS Hospital" are "Drug" (21 trials), "Other" (5 trials), "Diagnostic Test" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Biochemistry blood test" (2 trials), "ECG" (2 trials), "Hematology blood test" (2 trials) and "Ontamalimab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nazareth EMMS Hospital" are 21 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Nazareth EMMS Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Nazareth EMMS Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Nazareth EMMS Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".